Drugs / Aluminum Hydroxide Adjuvant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT03382418 Background | Dec 2017 → Sep 2019 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 2 | NCT03755427 Comparator | Nov 2018 → Jan 2019 | avian influenza | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aluminum Hydroxide Adjuvant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03755427 ↗ |